ConductScience.org, home
Papers
API referenceFor AI assistants

Paper · 39596194

Use of 3' Rapid Amplification of cDNA Ends (3' RACE)-Based Targeted RNA Sequencing for Profiling of Druggable Genetic Alterations in Urothelial Carcinomas.

Mitiushkina NV and 11 others. Int J Mol Sci, 2024. Cited by 1 paper, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Use of 3' Rapid Amplification of cDNA Ends (3' RACE)-Based Targeted RNA Sequencing for Profiling of Druggable Genetic Alterations in Urothelial Carcinomas. Papers, record 39596194. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39596194

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Use of 3' Rapid Amplification of cDNA Ends (3' RACE)-Based Targeted RNA Sequencing for Profiling of Druggable Genetic Alterations in Urothelial Carcinomas.
PubMed
Journal
Int J Mol Sci
PubMed
Year
2024
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
1
iCite
Relative citation ratio, by iCite
0.22, provisional
iCite
Revised in PubMed
2024-11-30
PubMed

Authors12

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Mitiushkina NVNatalia Vhttps://orcid.org/0000-0002-0179-3191
2Tiurin VIVladislav Ihttps://orcid.org/0000-0002-0157-5952
3Anuskina AAAleksandra A
4Bordovskaya NANatalia Ahttps://orcid.org/0009-0003-5583-4221
5Nalivalkina EAEkaterina Ahttps://orcid.org/0009-0000-1955-1433
6Terina DMDarya M
7Berkut MVMariya Vhttps://orcid.org/0000-0002-6276-1716
8Shestakova ADAnna D
9Syomina MVMaria Vhttps://orcid.org/0009-0003-3206-2871
10Kuligina ESEkaterina Shhttps://orcid.org/0000-0002-2396-6540

1 to 10 of 12Source PubMed

See all 12 authors

Topics12

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Sequence Analysis, RNAMajor topic
Humans
Male
Female
Aged
Middle Aged
Mutation
Urinary Bladder Neoplasms
Aged, 80 and over
Receptor, Fibroblast Growth Factor, Type 3
Receptor, Fibroblast Growth Factor, Type 2
Adult

Source PubMed

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
22-15-00487Russian Science FoundationPubMed

Source PubMed

Trials0

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

None in this release.

Comments and corrections0

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

None in this release.

References55

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
138,572,751Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.CA Cancer J Clin2024https://conductscience.org/library/papers/38572751PubMed
239,366,934The genomic and transcriptomic landscape of metastastic urothelial cancer.Nat Commun2024https://conductscience.org/library/papers/39366934PubMed
338,542,278Targeting KRAS G12C Mutation in Colorectal Cancer, A Review: New Arrows in the Quiver.Int J Mol Sci2024https://conductscience.org/library/papers/38542278PubMed
432,727,882Tipifarnib as a Precision Therapy for HRAS-Mutant Head and Neck Squamous Cell Carcinomas.Mol Cancer Ther2020https://conductscience.org/library/papers/32727882PubMed
538,102,374Exploratory analyses of treatment subgroup interaction by PD-L1 status and according to PD-L1 expression in the JAVELIN Bladder 100 trial.Clin Transl Oncol2024https://conductscience.org/library/papers/38102374PubMed
638,155,921Advances in HER2-Targeted Treatment for Advanced/Metastatic Urothelial Carcinoma.Bladder (San Franc)2023https://conductscience.org/library/papers/38155921PubMed
726,373,574The FGFR Landscape in Cancer: Analysis of 4,853 Tumors by Next-Generation Sequencing.Clin Cancer Res2016https://conductscience.org/library/papers/26373574PubMed
838,490,358ESMO Clinical Practice Guideline interim update on first-line therapy in advanced urothelial carcinoma.Ann Oncol2024https://conductscience.org/library/papers/38490358PubMed
933,704,186A Rare p.T599dup BRAF Mutant NSCLC in a Non-Smoker.Curr Oncol2020https://conductscience.org/library/papers/33704186PubMed
1035,459,782Targeting farnesylation as a novel therapeutic approach in HRAS-mutant rhabdomyosarcoma.Oncogene2022https://conductscience.org/library/papers/35459782PubMed

1 to 10 of 55

See all 55 references

Cited by1

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1 citation.

PMIDTitleJournalYearIn Papers
42,653,2305' Rapid Amplification of cDNA Ends (5' RACE)-Based Targeted RNA Sequencing Assay for the Analysis of Clinically Relevant Alterations in Lung Cancer Patients.Int J Mol Sci2026https://conductscience.org/library/papers/42653230

Source PubMed

Genes9

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
BRAF673PubTator's text mininghttps://conductscience.org/library/genes/673NCBI Gene
CD27429,126PubTator's text mininghttps://conductscience.org/library/genes/29126NCBI Gene
ERBB22,064PubTator's text mininghttps://conductscience.org/library/genes/2064NCBI Gene
FGFR22,263PubTator's text mininghttps://conductscience.org/library/genes/2263NCBI Gene
FGFR32,261PubTator's text mininghttps://conductscience.org/library/genes/2261NCBI Gene
KRAS3,845PubTator's text mininghttps://conductscience.org/library/genes/3845NCBI Gene
NRAS4,893PubTator's text mininghttps://conductscience.org/library/genes/4893NCBI Gene
PIK3CA5,290PubTator's text mininghttps://conductscience.org/library/genes/5290NCBI Gene
ZHX222,882PubTator's text mininghttps://conductscience.org/library/genes/22882NCBI Gene

Drugs0

The drugs whose trials, in the Pipelines release, list the paper.

None in this release.

Data0

The data bank entries PubMed's record names. Trial numbers are under Trials.

None in this release.

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39596194

GET https://conductscience.org/api/papers/v1/39596194/references?page=2

API referenceFor AI assistants